Showing results (31-40 of 82) with videos related to
Sort By:
Pageof 9
The Journal of Membrane Biology|October 15, 1979
Alterations of the carrier-mediated transport of an anionic solute, methotrexate, by charged liposomes in Ehrlich ascites tumor cellsD W Fry, J C White, I D GoldmanJournal of Medicinal Chemistry|July 1, 1986
Basically substituted ellipticine analogues as potential antitumor agentsL M Werbel, M Angelo, D W Fry, et al.Journal of Medicinal Chemistry|March 4, 1994
Tyrosine kinase inhibitors. 2. Synthesis of 2,2'-dithiobis(1H-indole-3-alkanamides) and investigation of their inhibitory activity against epidermal growth factor receptor and pp60v-src protein tyrosine kinasesA M Thompson, D W Fry, A J Kraker, et al.Advances in Experimental Medicine and Biology|January 1, 1983
Characteristics of the accumulation of methotrexate polyglutamate derivatives in Ehrlich ascites tumor cells and isolated rat hepatocytesD W Fry, D A Gewirtz, J C Yalowich, et al.Biochemical Pharmacology|October 1, 1985
In vitro DNA strand scission and inhibition of nucleic acid synthesis in L1210 leukemia cells by a new class of DNA complexers, the anthra[1,9-cd]pyrazol-6(2H)-ones (anthrapyrazoles)D W Fry, T J Boritzki, J A Besserer, et al.Molecular and Cellular Biology|June 22, 1999
Induced focal adhesion kinase (FAK) expression in FAK-null cells enhances cell spreading and migration requiring both auto- and activation loop phosphorylation sites and inhibits adhesion-dependent tyrosine phosphorylation of Pyk2J D Owen, P J Ruest, D W Fry, et al.Cancer Research|July 1, 1980
Relationship between membrane transport of methotrexate and endogenous cyclic adenosine 3':5'-monophosphate in the Ehrlich ascites tumorJ C White, R A Carchman, D W Fry, et al.Cancer Letters|June 1, 1986
Cross resistance of pleiotropically drug resistant P338 leukemia cells to the lipophilic antifolates trimetrexate and BW 301UW D Klohs, R W Steinkampf, J A Besserer, et al.Journal of Medicinal Chemistry|July 1, 1990
Potent inhibition of thymidylate synthase by two series of nonclassical quinazolinesD J McNamara, E M Berman, D W Fry, et al.Bioorganic & Medicinal Chemistry|December 1, 1995
Enantioselective inhibition of the epidermal growth factor receptor tyrosine kinase by 4-(alpha-phenethylamino)quinazolinesA J Bridges, D R Cody, H Zhou, et al.Pageof 9